Square Pharmaceuticals Limited

---

Company Profile
Square Pharmaceuticals Ltd. was established in 1958 as a private partnership business manufacturing pharmaceuticals products. In 1964, it was incorporated as a private limited company. Later in 1991, the company became a public limited company and consequently listed in stock exchange in 1995. 54.16% of its total shares are held by the sponsors. The company has been the largest producer in pharmaceuticals industry since 1985 and is the present market leader.
Key Revenue Driver & Company Insight
Square Pharma's revenue comes from sales of Pharmaceuticals products as well as from its investments and subsidiaries. Among these, pharmaceutical products serve as the core of revenue, providing 85% of Gross turnover (5 Year Avg). Alongside pharmaceuticals business, Square Pharma also has several subsidiaries and investments. Among these mentionable ones are Square Spinning Ltd. Square Cephalosporin Ltd., Square Textile Ltd, Square Hospitals Ltd., Square Fashions Ltd, etc.
The pharmaceuticals industry is experiencing a good growth, approximately 23% (IMS Data) in 2010. Whereas Square Pharma, the market leader had a growth of 23.80% and a market share of 19.19%. Established position, strong branding coupled with growth in domestic and export market serve as the key driver to its success.
Financial Performance
32% growth in NPAT and 2% growth in ROE had been observed in 2011. Strong Industry position, healthy cash flows and efficient management in a growing industry are the prime reasons of such good financial performance.